Chemical Biology

Our Services

  • •Synthesis of core intermediate on 1-3 g scale (ease of synthesis)

    •Library small molecule chemistry carried out on 10-50 mg scale

    •Initial small molecule library will contain ‘hit’ and diverse analogues to explore SAR

  • •Post reaction work-up carried out using solid phase reagents

    •All compounds have LC-MS checks to determine reaction success and purification requirements

    •All compounds requiring purification are carried out via preparative HPLC/SFC

  • •In house electronic notebook and compound registration systems in place

    •Individual projects ring-fenced and firewalled to protect information

    •All final compounds accurately weighed, barcoded and tracked

  • All compounds screened in desired biological assays (biochemical and/or cell based)

    •Data generated used to inform next iteration  of compound library generation

    •Off-target screening

    •In addition, rounds of more focussed libraries, such as solubility, stability, cLogP (partner)

    • Carry out standard analytical screening to support chiral chemistry project – determination of %ee

    • Identify chiral separation methods for scaling up to semi-preparative chromatography

Capabilities

Located in The Johnston Cancer Research Centre (JCRC), gain access to our chemical biology team that has extensive research in developing potent and selective compounds.

•Technology Enabled Synthesis or TES is a medicinal chemistry platform that allows for rapid SAR (Structure Activity Relationship) during the ‘Hit validation’ and early ‘Hit to lead’ programmes

•Using cutting edge technologies, we can carry out early-stage drug development work in a pre-competitive environment

Team

Dr Rich Williams

Academic Lead

Small molecule inhibitor development/ protease biology

Robert Haydon

Research Technician

Process scale-up, chemical analysis

Dr. Emma Clyde Allen

Research Fellow

Small molecule inhibitor development/ protease biology

Dr Benjamin Owen

Research Fellow

Drug development

FMI Chiral Screening Lab

The FMI has established a chiral analytical and semi-preparative chromatography hub. Utilising the SFC system recently installed in the FMI, we have recently acquired a range of chiral analytical columns, that cover a broad range of stationary phases, to carry out a systematic screening program with the aim of identifying methods for separating mixtures of enantiomers. This system can be used to:

  1. carry out standard analytical screening to support chiral chemistry project – determination of %ee

  2. identify chiral separation methods for scaling up to semi-preparative chromatography

For accessing the analytical technologies, please contact FMI@qub.ac.uk. Ideally samples should be submitted as a dry powder (3-5 mg) for chiral method development and less than 1 mg for analysis of samples with pre-established screening.

For preparative separation, once an analytical method is identified from the chiral screening, we will acquire a semi-preparative column upon agreement of a body of work with the collaborator to carry out purifying racemic materials (10 mg to 1 g). Prices for the separation services will be agreed between the FMI and collaborator prior to work commencing. All final purified materials will be concentrated to dryness for supplying to the collaborator with a full analytical check (chiral and standard analytical column) to ensure purity.

 

Our technology

 

Visit us

The Patrick G. Johnston Centre for Cancer Research 97 Lisburn Rd, Belfast BT9 7AE

Hours
Monday–Friday
8am–5pm

Email rich.wiliams@qub.ac.uk